Terms: = Sarcomas AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
16 results:
1. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
2. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
Travaglino A; Raffone A; Raimondo D; Arciuolo D; Angelico G; Valente M; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Santoro A; Seracchioli R; Franco Zannoni G
Int J Gynaecol Obstet; 2022 Jul; 158(1):13-20. PubMed ID: 34536971
[TBL] [Abstract] [Full Text] [Related]
3. Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
Valenciaga A; Iwenofu OH; Tinoco G
J Natl Compr Canc Netw; 2021 Jul; 19(7):775-779. PubMed ID: 34340207
[TBL] [Abstract] [Full Text] [Related]
4. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
Singh TP; Sharma A; Sharma A; Bakhshi S; Patel C; Pandey AK; Dhamija E; Batra A; Kumar R
Nucl Med Commun; 2021 Jul; 42(7):818-825. PubMed ID: 33741856
[TBL] [Abstract] [Full Text] [Related]
5. Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient.
Feroce F; Cantile M; Aquino G; Collina F; Scognamiglio G; Castaldo L; Perdonà S; Botti G; De Chiara A
Pathol Res Pract; 2020 Aug; 216(8):153033. PubMed ID: 32703497
[TBL] [Abstract] [Full Text] [Related]
6. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract] [Full Text] [Related]
7. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
[TBL] [Abstract] [Full Text] [Related]
8. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract] [Full Text] [Related]
9. Biallelic
Hanna JA; Drummond CJ; Garcia MR; Go JC; Finkelstein D; Rehg JE; Hatley ME
Cancer Res; 2017 Nov; 77(22):6109-6118. PubMed ID: 28916654
[TBL] [Abstract] [Full Text] [Related]
10. Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.
Pectasides D; Kotoula V; Papaxoinis G; Alexopoulou Z; Dervenis C; Samantas E; Papaparaskeva K; Charalambous E; Gkakou C; Agalianos C; Kalogeras KT; Pentheroudakis G; Fountzilas G
Anticancer Res; 2016 Dec; 36(12):6347-6356. PubMed ID: 27919956
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.
Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT
Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.
Jardim DL; Conley A; Subbiah V
Orphanet J Rare Dis; 2013 Jul; 8():112. PubMed ID: 23895135
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.
Martin-Broto J; Gutierrez A; Garcia-Del-Muro X; Lopez-Guerrero JA; Martinez-Trufero J; de Sande LM; Lainez N; Maurel J; De Juan A; Losa F; Andres R; Casado A; Tejido PG; Blanco R; Carles J; Bellmunt J; Gomez-España A; Ramos R; Martinez-Serra J; Llombart-Bosch A; Poveda A
Ann Oncol; 2010 Jul; 21(7):1552-1557. PubMed ID: 20231303
[TBL] [Abstract] [Full Text] [Related]
14. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract] [Full Text] [Related]
15. Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization.
Nakagawa Y; Numoto K; Yoshida A; Kunisada T; Ohata H; Takeda K; Wai D; Poremba C; Ozaki T
J Cancer Res Clin Oncol; 2006 Jul; 132(7):444-50. PubMed ID: 16557383
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas.
Kim SH; Lewis JJ; Brennan MF; Woodruff JM; Dudas M; Cordon-Cardo C
Clin Cancer Res; 1998 Oct; 4(10):2377-82. PubMed ID: 9796968
[TBL] [Abstract] [Full Text] [Related]